Acute generalized exanthematous pustulosis associated with STI571 in a patient with chronic myeloid leukemia

Dermatology

Volumn 203, Issue 1, 2001, Pages 57-59

  Brouard, M C ^a,b   Prins, C ^a   Mach Pascual, S ^a   Saurat, J H ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b University Hospital   (Switzerland)

Author keywords

Adverse drug reaction; Leukemia; Tyrosine kinase inhibitor

Indexed keywords

ANTINEOPLASTIC AGENT; IMATINIB; PROTEIN TYROSINE KINASE INHIBITOR;

ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DRUG INDUCED DISEASE; ENZYME ACTIVITY; FEMALE; HUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PUSTULOSIS; RASH; SKIN BIOPSY; SKIN MANIFESTATION; URTICARIA;

ACUTE DISEASE; ADULT; ANTINEOPLASTIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG ERUPTIONS; ENZYME INHIBITORS; EXANTHEMA; FEMALE; HUMANS; LEUKEMIA, MYELOID, CHRONIC; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES;

EID: 0034837552     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051705     Document Type: Article

References (18)

1. Acute generalized exanthematous pustulosis: Analysis of 63 cases
2. Acute generalized exanthematous pustulosis (AGEP) - A clinical reaction pattern
3. Acute generalized exanthematous pustulosis induced by ingestion of lacquer chicken
4. Acute generalized exanthematous pustulosis - An apoptotic process as suggested by immunohistochemical analysis?
5. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells
6. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia
7. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome
8. Structural mechanism for STI-571 inhibition of abelson tyrosine kinase
9. The tyrosine kinase inhibitor CGP 57148 (STI 571) induces apoptosis in BCR-ABL-positive cells by down-regulating BCL-X
10. CGP57148B (STI-571) induces differentiation and apoptosis and sensitizes bcr-abl-positive human leukemia cells to apoptosis due to anti-leukemic drugs
11. Inhibition of c-kit receptor tyrosine kinase activity by STI 571, a selective tyrosine kinase inhibitor
12. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571
13. Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
14. 2+) stimulate glucose transport activity by post-insulin receptor kinase mechanism in rat adipocytes
15. Redox mechanism as alternative to ligand binding for receptor activation delivering disregulated cellular signals
16. Low and nontoxic levels of ionic mercury interfere with the regulation of cell growth in the WEHI-231 B-cell lymphoma
17. Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors
18. ARG tyrosine kinase activity is inhibited by STI571